Angola medical device regulations
Official sources linkedARMED rules and guidance for medical device market access, registration, and lifecycle compliance. Each code opens a metadata page with the official source and readable HTML when available.
| Code | Regulation | Category | Effective | Provenance |
|---|---|---|---|---|
| Decreto Executivo n.º 1/22, de 5 de Janeiro | Condições de certificação das Farmácias e Laboratórios de Análises Clínicas para a realização de testes de antigénio para a detecção do Vírus SARS-CoV-2 que causa a COVID-19 Historical Health Ministry decree with all seven articles and both annexes on SARS-CoV-2 antigen-testing service certification. It provides pharmacy authorization conditions, updated pharmacy/test lists, ReDIV reporting, two printed reporting forms and attached positive-result procedures. The Gazette is dated 5 January 2022 and the ministerial text is dated 30 December 2021. This pandemic service source is not a general device market-authorization rule; later measures and current applicability remain unverified. | General | — | Official |
| Decreto Presidencial n° 136/21, de 1 de junho | Criação e Estatuto Orgânico da Agência Reguladora de Medicamentos e Tecnologias de Saúde Complete decree and organic statute establishing ARMED, including its device/health-technology registration, licensing, inspection, vigilance, clinical-trial and quality-control powers and the three organisational annexes. The Gazette scan is preserved by LEX.AO. Unrelated Gazette contents before and after the instrument are excluded. The separate government education-ministry PDF omits intermediate pages of this decree and was therefore not used as the corpus source. | General | — | Official |
| Despacho nº 05/ARMED/MINSA/2022 | REQUISITOS DE DESALFANDEGAMENTO Complete two-page historical customs-clearance order dated 10 March 2022. Point 2 specifies Portuguese invoices and certificates of origin for equipment, adding an ARMED import certificate for rapid infectious-disease diagnostic tests; point 3 provides common application particulars. Medicine-specific requirements and personal-use provisions remain distinct. The source is an archived official PDF, with later instructions and current applicability unverified. | Registration | — | Official |
| Despacho nº 001/ARMED/MINSA/2022 | PROCEDIMENTOS DE IMPORTAÇÃO E COMERCIALIZAÇÃO DE TESTES DE DIAGNÓSTICO RÁPIDO PARA O RASTREIO E O DIAGNÓSTICO DE DOENÇAS INFECCIOSAS Historical ARMED order on infectious-disease rapid diagnostic tests, with the complete four-point order and Annex I. It addresses validated-test lists, prior import authorization, importer/manufacturer monitoring and technovigilance, and the INIS validation and release process. The annex refers to 300 samples per lot and a possible 20–40 day INIS response while stock remains detained; this is not a general device registration deadline. Retained from an archived official PDF dated 22 February 2022; later applicability and referenced test lists remain unverified. | Registration | — | Official |
| Despacho nº 03/ARMED/MINSA/2022 | RESTRIÇÃO DE IMPORTAÇÃO E COMERCIALIZAÇÃO DE AUTOTESTES PARA A SARS-COV-2 Complete historical one-page ARMED order dated 10 March 2022, addressing INIS-validated SARS-CoV-2 rapid tests and stating that importation and commercialization of SARS-CoV-2 self-tests are not authorized. Its pandemic-specific scope and printed 136/20 citation are retained. This archived official expression does not establish a restriction on all IVDs or prove current applicability. | Registration | — | Official |
What these codes are
Each row above represents one regulatory instrument. Its code is the authority’s identifier. A regulation page collects the metadata and official source; when readable HTML is available, article links can open and highlight the exact cited passage.
Continue from regulations into practical research
Keep Angola as the target market while you move into registration records, classification, cross-country product research, or pathway planning.
Compare products across markets
Search the same product in multiple country registries.
Build a registration plan
Estimate pathway, government fees, preparation, and review time.
Build a reusable product master
Structure company, product, model, approval, and evidence facts once.
Map dossier reuse and deltas
Compare existing evidence against Angola needs.
Build a market-launch workpaper
Connect route, evidence, labels, representatives, and launch dependencies.
Assess a regulatory change
Test a current ARMED update against one product and its evidence.